Sex Differences and the Role of Sex Steroids in Renal Injury

Journal of Urology

Volumn 176, Issue 1, 2006, Pages 15-21

  Metcalfe, Peter D ^a   Meldrum, Kirstan K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; gonadal steroid hormones; inflammation; kidney; wounds and injuries

Indexed keywords

ANGIOTENSIN II; CASPASE 9; CREATININE; CYTOCHROME C; ENDOTHELIN; ESTROGEN; IMMUNOGLOBULIN A; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN BAD; PROTEIN BCL 2; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC KIDNEY FAILURE; CLINICAL RESEARCH; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; ESTROGEN ACTIVITY; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUMOR; NEPHRON; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

ANIMALS; APOPTOSIS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY FAILURE; MALE; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 33744542848     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(06)00490-3     Document Type: Article

References (84)

1. Squadrito F., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Arcoraci V., et al. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol 335 (1997) 185
2. Wang M., Baker L., Tsai B.M., Meldrum K.K., and Meldrum D.R. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 288 (2005) E321
3. Park K.M., Kim J.I., Ahn Y., Bonventre A.J., and Bonventre J.V. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 279 (2004) 52282
4. Verzola D., Gandolfo M.T., Salvatore F., Villaggio B., Gianiorio F., Traverso P., et al. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int 65 (2004) 1252
5. Wang M., Tsai B.M., Kher A., Baker L.B., Wairiuko G.M., and Meldrum D.R. Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol 288 (2005) H221
6. United States Renal Data System Annual Data Report. Atlas of End-Stage Kidney Disease in the United States (2001), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
7. Iseki K., Ikemiya Y., and Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 51 (1997) 850
8. Simon P., Ramee M.P., Autuly V., Laruelle E., Charasse C., Cam G., et al. Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int 46 (1994) 1192
9. Neugarten J., Acharya A., and Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease. a meta-analysis. J Am Soc Nephrol 11 (2000) 319
10. Silbiger S.R., and Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25 (1995) 515
11. Rekola S., Bergstrand A., and Bucht H. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int 40 (1991) 1050
12. Donadio Jr. J.V., Torres V.E., Velosa J.A., Wagoner R.D., Holley K.E., Okamura M., et al. Idiopathic membranous nephropathy. the natural history of untreated patients. Kidney Int 33 (1988) 708
13. United States Renal Data System. USRDS 2002 Annual Data Report. Atlas of End-Stage Renal Disease in the United States (2002), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
14. West K.M., Erdreich L.J., and Stober J.A. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29 (1980) 501
15. Held P.J., Port F.K., Blagg C.R., and Agodoa L.Y. The United States Renal Data System's 1990 Annual Data Report. an introduction. Am J Kidney Dis 16 (1990) i
16. Lawson M.L., Sochett E.B., Chait P.G., Balfe J.W., and Daneman D. Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM. Diabetes 45 (1996) 51
17. Silbiger S.R., and Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther 10 (2003) 3
18. Sharma K., Ziyadeh F.N., Alzahabi B., McGowan T.A., Kapoor S., Kurnik B.R., et al. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 46 (1997) 854
19. Segura J., Campo C., Gil P., Roldan C., Vigil L., Rodicio J.L., et al. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. J Am Soc Nephrol 15 (2004) 1616
20. Hannedouche T., Chauveau P., Kalou F., Albouze G., Lacour B., and Jungers P. Factors affecting progression in advanced chronic renal failure. Clin Nephrol 39 (1993) 312
21. Jungers P., Hannedouche T., Itakura Y., Albouze G., Descamps-Latscha B., and Man N.K. Progression rate to end-stage renal failure in non-diabetic kidney diseases. a multivariate analysis of determinant factors. Nephrol Dial Transplant 10 (1995) 1353
22. Hollenberg N.K., Adams D.F., Solomon H.S., Rashid A., Abrams H.L., and Merrill J.P. Senescence and the renal vasculature in normal man. Circ Res 34 (1974) 309
23. Baltatu O., Cayla C., Iliescu R., Andreev D., Jordan C., and Bader M. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol 13 (2002) 2681
24. Reckelhoff J.F., Zhang H., Srivastava K., and Granger J.P. Gender differences in hypertension in spontaneously hypertensive rats. role of androgens and androgen receptor. Hypertension 34 (1999) 920
25. Gretz N., Zeier M., Geberth S., Strauch M., and Ritz E. Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 14 (1989) 178
26. Conte F., Serbelloni P., Milani S., Sessa A., and Italian ADPKD Cooperative Study Group. Clinical data of a cooperative Italian study of ADPKD. Contrib Nephrol 115 (1995) 72 Autosomal Dominant Polycystic Kidney Disease
27. Chertow G.M., Lazarus J.M., Paganini E.P., Allgren R.L., Lafayette R.A., Sayegh M.H., and The Auriculin Anaritide Acute Renal Failure Study Group. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. J Am Soc Nephrol 9 (1998) 692
28. Obialo C.I., Crowell A.K., and Okonofua E.C. Acute renal failure mortality in hospitalized African Americans. age and gender considerations. J Natl Med Assoc 94 (2002) 127
29. Gesualdo L., Di Palma A.M., Morrone L.F., Strippoli G.F., and Schena F.P. The Italian experience of the national registry of renal biopsies. Kidney Int 66 (2004) 890
30. Schena F.P., and The Italian Group of Renal Immunopathology. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. Nephrol Dial Transplant 12 (1997) 418
31. Heaf J., Lokkegaard H., and Larsen S. The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997. Nephrol Dial Transplant 14 (1999) 1889
32. Muller V., Losonczy G., Heemann U., Vannay A., Fekete A., Reusz G., et al. Sexual dimorphism in renal ischemia-reperfusion injury in rats. possible role of endothelin. Kidney Int 62 (2002) 1364
33. Park K.M., Cho H.J., and Bonventre J.V. Orchiectomy reduces susceptibility to renal ischemic injury. a role for heat shock proteins. Biochem Biophys Res Commun 328 (2005) 312
34. Voss M.R., Stallone J.N., Li M., Cornelussen R.N., Knuefermann P., and Knowlton A.A. Gender differences in the expression of heat shock proteins. the effect of estrogen. Am J Physiol Heart Circ Physiol 285 (2003) H687
35. Han H.J., Park S.H., Park H.J., Lee J.H., Lee B.C., and Hwang W.S. Effects of sex hormones on Na+/glucose cotransporter of renal proximal tubular cells following oxidant injury. Kidney Blood Press Res 24 (2001) 159
36. Misseri R., Rink R.C., Meldrum D.R., and Meldrum K.K. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res 119 (2004) 149
37. Guo G., Morrissey J., McCracken R., Tolley T., Liapis H., and Klahr S. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 280 (2001) F777
38. Misseri R., Meldrum D.R., Dinarello C.A., Dagher P., Hile K.L., Rink R.C., et al. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 288 (2005) F406
39. Rossouw J.E. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 53 (2002) 550
40. Hodis H.N., and Mack W.J. Atherosclerosis imaging methods. assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 89 (2002) 19E
41. Neugarten J., and Silbiger S.R. Effects of sex hormones on mesangial cells. Am J Kidney Dis 26 (1995) 147
42. Fekete A., Vannay A., Ver A., Vasarhelyi B., Muller V., Ouyang N., et al. Sex differences in the alterations of Na(+), K(+)-ATPase following ischaemia-reperfusion injury in the rat kidney. J Physiol 555 (2004) 471
43. Mulroney S.E., Woda C., Johnson M., and Pesce C. Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int 56 (1999) 944
44. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94 (1994) 1823
45. Kang D.H., Yu E.S., Yoon K.I., and Johnson R. The impact of gender on progression of renal disease. potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 164 (2004) 679
46. Lombet J.R., Adler S.G., Anderson P.S., Nast C.C., Olsen D.R., and Glassock R.J. Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114 (1989) 66
47. Gross M.L., Adamczak M., Rabe T., Harbi N.A., Krtil J., Koch A., et al. Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol 15 (2004) 348
48. Wilhelm S.M., Stowe N.T., Robinson A.V., and Schulak J.A. The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation 71 (2001) 211
49. Polderman K.H., Stehouwer C.D., van Kamp G.J., Dekker G.A., Verheugt F.W., and Gooren L.J. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118 (1993) 429
50. Ylikorkala O., Orpana A., Puolakka J., Pyorala T., and Viinikka L. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 80 (1995) 3384
51. Dubey R.K., Jackson E.K., Keller P.J., Imthurn B., and Rosselli M. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 37 (2001) 640
52. Akishita M., Kozaki K., Eto M., Yoshizumi M., Ishikawa M., Toba K., et al. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun 251 (1998) 17
53. Martinez-Mier G., Toledo-Pereyra L.H., Bussell S., Gauvin J., Vercruysse G., Arab A., et al. Nitric oxide diminishes apoptosis and p53 gene expression after renal ischemia and reperfusion injury. Transplantation 70 (2000) 1431
54. Schneider R., Raff U., Vornberger N., Schmidt M., Freund R., Reber M., et al. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 64 (2003) 216
55. Neugarten J., Ding Q., Friedman A., Lei J., and Silbiger S. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 8 (1997) 1240
56. Reckelhoff J.F., Hennington B.S., Moore A.G., Blanchard E.J., and Cameron J. Gender differences in the renal nitric oxide (NO) system. dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 11 (1998) 97
57. Hopkins P.N., Lifton R.P., Hollenberg N.K., Jeunemaitre X., Hallouin M.C., Skuppin J., et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14 (1996) 199
58. Fisher N.D., Ferri C., Bellini C., Santucci A., Gleason R., Williams G.H., et al. Age, gender, and non-modulation. A sexual dimorphism in essential hypertension. Hypertension 29 (1997) 980
59. Miller J.A., Anacta L.A., and Cattran D.C. Impact of gender on the renal response to angiotensin II. Kidney Int 55 (1999) 278
60. Meldrum K.K., Meldrum D.R., Hile K.L., Yerkes E.B., Ayala A., Cain M.P., et al. p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 281 (2001) C563
61. Haq M., Norman J., Saba S.R., Ramirez G., and Rabb H. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 9 (1998) 614
62. Misseri R., Meldrum D.R., Dagher P., Hile K., Rink R.C., and Meldrum K.K. Unilateral ureteral obstruction induces renal tubular cell production of tumor necrosis factor-alpha independent of inflammatory cell infiltration. J Urol 172 (2004) 1595
63. Guan Z., Buckman S.Y., Springer L.D., and Morrison A.R. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells. J Biol Chem 274 (1999) 36200
64. Kaneto H., Morrissey J., and Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44 (1993) 313
65. Lane P.H., Snelling D.M., Hollman A., and Langer W.J. Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes. Pediatr Nephrol 16 (2001) 1033
66. Blush J., Lei J., Ju W., Silbiger S., Pullman J., and Neugarten J. Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice. Kidney Int 66 (2004) 2148
67. Wu M.F., Chang H.L., and Tseng J. Dehydroepiandrosterone induces the transforming growth factor-beta production by murine macrophages. Int J Tissue React 19 (1997) 141
68. Kang H.Y., Lin H.K., Hu Y.C., Yeh S., Huang K.E., and Chang C. From transforming growth factor-beta signaling to androgen action. identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc Natl Acad Sci USA 98 (2001) 3018
69. Matsuda T., Yamamoto T., Muraguchi A., and Saatcioglu F. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 276 (2001) 42908
70. Antus B., Yao Y., Song E., Liu S., Lutz J., and Heemann U. Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 15 (2002) 494
71. Klahr S., and Morrissey J.J. The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18 (1998) 622
72. Ortiz A., Bustos C., Alonso J., Alcazar R., Lopez-Armada M.J., Plaza J.J., et al. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 24 (1995) 53
73. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81 (1995) 495
74. Moxley G., Stern A.G., Carlson P., Estrada E., Han J., and Benson L.L. Premenopausal sexual dimorphism in lipopolysaccharide-stimulated production and secretion of tumor necrosis factor. J Rheumatol 31 (2004) 686
75. Bouman A., Moes H., Heineman M.J., de Leij L.F., and Faas M.M. The immune response during the luteal phase of the ovarian cycle. increasing sensitivity of human monocytes to endotoxin. Fertil Steril 76 (2001) 555
76. Posma E., Moes H., Heineman M.J., and Faas M.M. The effect of testosterone on cytokine production in the specific and non-specific immune response. Am J Reprod Immunol 52 (2004) 237
77. Stapleton P.P., Strong V.E., Freeman T.A., Winter J., Yan Z., and Daly J.M. Gender affects macrophage cytokine and prostaglandin E2 production and PGE2 receptor expression after trauma. J Surg Res 122 (2004) 1
78. Dougherty C.J., Kubasiak L.A., Prentice H., Andreka P., Bishopric N.H., and Webster K.A. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J 362 (2002) 561
79. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739
80. Zheng T.S., Hunot S., Kuida K., and Flavell R.A. Caspase knockouts. matters of life and death. Cell Death Differ 6 (1999) 1043
81. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770
82. Chinnaiyan A.M., O'Rourke K., Tewari M., and Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 (1995) 505
83. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231
84. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., and Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101 (2000) 660